Yuan‐Hung Kuo

发表

The impact of general anesthesia on radiofrequency ablation of hepatocellular carcinoma

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2014, The Kaohsiung journal of medical sciences.

Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2010, Scandinavian journal of gastroenterology.

Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C.

Sheng-Nan Lu, Chi-Chih Wang, Jing-Houng Wang, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2017, Journal of gastroenterology and hepatology.

The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Investigational New Drugs.

First‐line Helicobacter pylori eradication among patients with chronic liver diseases in Taiwan

Keng-Liang Wu, S. Chuah, Y. Chiu, 2016, The Kaohsiung journal of medical sciences.

Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.

Ming‐Luen Hu, S. Chuah, T. Hu, 2015, World journal of gastroenterology.

Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan Retrospective Study

Ming‐Luen Hu, S. Chuah, W. Tai, 2015 .

Effect of gut microbiota and PNPLA3 polymorphisms on nonalcoholic fatty liver disease in lean and obese individuals

S. Chuah, W. Tai, Chih-Chien Yao, 2024, Advances in Digestive Medicine.

Sorafenib use in hepatitis B virus‐ or hepatitis C virus‐related hepatocellular carcinoma: A propensity score matching study

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, The Kaohsiung journal of medical sciences.

Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening

Sheng-Nan Lu, Jing-Houng Wang, C. Hsiao, 2019, PloS one.

Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care

Sheng-Nan Lu, Jing-Houng Wang, Kuo-Chin Chang, 2015, PloS one.

Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2023, Diagnostics.

Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C.

C.-H. Chen, S. Chuah, Chao-Hung Hung, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Viruses.

A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2017, Clinical and Translational Gastroenterology.

Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease

S. Chuah, Chien-Ning Hsu, W. Tai, 2015, BMC Gastroenterology.

Tenofovir versus Entecavir in Treatment of Chronic Hepatitis B Virus with Severe Acute Exacerbation

Sheng-Nan Lu, Chien-Hung Chen, C.-H. Chen, 2015, Antimicrobial Agents and Chemotherapy.

The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2014, PloS one.

Role of hepatitis C virus substitutions and interleukin‐28B polymorphism on response to peginterferon plus ribavirin in a prospective study of response‐guided therapy

Kuo-Chin Chang, Chih‐Ming Liang, C-H Chen, 2013, Journal of viral hepatitis.

The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventions

Sheng-Nan Lu, Chien-Hung Chen, Keng-Liang Wu, 2013, Hepatology International.

Natural course of hepatic focal nodular hyperplasia: A long‐term follow‐up study with sonography

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2009, Journal of clinical ultrasound : JCU.

Hepatocellular carcinoma detected by regular surveillance: Does timely confirmation of diagnosis matter?

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population‐based study

Sheng-Nan Lu, Jing-Houng Wang, C. Hsiao, 2018, Alimentary pharmacology & therapeutics.

Editorial: hepatitis B, fatty liver and metabolic syndrome—Interaction or co‐existence? Authors’ reply

Sheng-Nan Lu, Yuan-Hung Kuo, Yuan‐Hung Kuo, 2018, Alimentary pharmacology & therapeutics.

Distinct gut microbiota alterations in patients with early‐stage and advanced‐stage hepatocellular carcinoma

S. Chuah, Jing-Houng Wang, W. Tai, 2024, Advances in Digestive Medicine.

Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2013, The American Journal of Gastroenterology.

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2023, BMC Cancer.

The Efficacy and Safety of Ramucirumab in Heavily Pretreated Advanced Hepatocellular Carcinoma

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2023, AntiCancer Research.

Low-dose nivolumab in advanced hepatocellular carcinoma

Jing-Houng Wang, Chao-Hung Hung, Yen-Yang Chen, 2022, BMC Cancer.

Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2022, Cancers.

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab

Chi-Chih Wang, Jing-Houng Wang, Chao-Hung Hung, 2022, Cancers.

A comparison between non-sedation and general endotracheal anesthesia for retrograde endoscopic common bile duct stone removal: A tertiary center experience

C. Changchien, S. Chuah, Y. Chiu, 2019, Biomedical journal.

Is Hepatitis C Virus Core Antigen an Adequate Marker for Community Screening?

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2012, Journal of Clinical Microbiology.

Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies

Yueh-Wei Liu, K. Kee, Chih-Yun Lin, 2024, PloS one.

Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation.

Kuo-Chin Chang, Y. Chou, Po-Lin Tseng, 2023, Journal of infection and public health.